Purchases and Sales Made in Q4 2023 in Utah Medical Products Inc (UTMD)
This table provides information about the institutional ownership of Utah Medical Products Inc (UTMD) during Q4 2023. The information is specifically focused on institutions that hold shares of UTAH MEDICAL PRODUCTS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-155- 6.16% |
$11.9K - $13.5K
|
2.36K
$141K
|
|
|
Feb 13, 2024
Q4 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-192- 25.36% |
$14.8K - $16.7K
|
565
$33.7K
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-212- 4.5% |
$16.3K - $18.5K
|
4.5K
$269K
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-330- 2.28% |
$25.4K - $28.7K
|
14.2K
$846K
|
|
|
Jan 25, 2024
Q4 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-607- 99.51% |
$46.8K - $52.8K
|
3
$179
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-900- 0.44% |
$69.4K - $78.3K
|
205K
$12.2M
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-1.01K- 52.12% |
$77.7K - $87.7K
|
926
$55.3K
|
|
|
Feb 07, 2024
Q4 2023
|
Seizert Capital Partners, LLC
|
SELL
|
- |
-1.14K- 21.69% |
$87.9K - $99.3K
|
4.12K
$246K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.3K- 89.58% |
$100K - $113K
|
151
$9.01K
|
|
|
Feb 13, 2024
Q4 2023
|
Loomis Sayles & CO L P
|
SELL
|
- |
-1.59K- 3.45% |
$122K - $138K
|
44.4K
$2.65M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-1.6K- 15.53% |
$123K - $139K
|
8.7K
$519K
|
|
|
Feb 13, 2024
Q4 2023
|
Quadrature Capital LTD
London, X0 |
SELL
|
- |
-1.72K- 12.9% |
$133K - $150K
|
11.6K
$694K
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.98K- 8.26% |
$153K - $172K
|
22K
$1.31M
|
|
|
Feb 06, 2024
Q4 2023
|
Lsv Asset Management
Chicago, IL |
SELL
|
- |
-2.77K- 14.42% |
$214K - $241K
|
16.4K
$981K
|
|
|
Feb 13, 2024
Q4 2023
|
Globeflex Capital L P
San Diego, CA |
SELL
|
- |
-3K- 32.15% |
$231K - $261K
|
6.34K
$378K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-3.2K- 29.89% |
$247K - $279K
|
7.51K
$448K
|
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-3.67K- 6.25% |
$283K - $319K
|
55K
$3.28M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-5.78K- 8.33% |
$446K - $503K
|
63.6K
$3.8M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-6.44K- 15.73% |
$497K - $561K
|
34.5K
$2.06M
|
|
|
Feb 08, 2024
Q4 2023
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-6.62K- 5.93% |
$510K - $577K
|
105K
$6.27M
|
|
|
Feb 12, 2024
Q4 2023
|
Royce & Associates LP
|
SELL
|
- |
-16.9K- 51.56% |
$1.3M - $1.47M
|
15.8K
$946K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-23.4K- 65.14% |
$1.8M - $2.03M
|
12.5K
$746K
|
|
|
Feb 14, 2024
Q4 2023
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-60.1K- 18.26% |
$4.64M - $5.24M
|
269K
$16.1M
|